1. Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial. Issue 5 (24th January 2013) Authors: Rantalaiho, Vappu Marianna; Kautiainen, Hannu; Korpela, Markku; Hannonen, Pekka J; Leirisalo-Repo, Marjatta; Möttönen, Timo Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 5(2013) Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both). Issue 7 (1st July 1999) Authors: Pertovaara, Marja; Korpela, Markku; Uusitalo, Hannu; Pukander, Juhani; Miettinen, Ari; Helin, Heikki; Pasternack, Amos Journal: Annals of the rheumatic diseases Issue: Volume 58:Issue 7(1999) Page Start: 423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000–8. Issue 5 (7th June 2012) Authors: Rantalaiho, Vappu Marianna; Kautiainen, Hannu; Järvenpää, Salme; Virta, Lauri; Pohjolainen, Timo; Korpela, Markku; Möttönen, Timo; Puolakka, Kari Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 5(2013) Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Do the 2010 ACR/EULAR or ACR 1987 classification criteria predict erosive disease in early arthritis?. Issue 5 (21st November 2012) Authors: Mäkinen, Heidi; Kaarela, Kalevi; Huhtala, Heini; Hannonen, Pekka J; Korpela, Markku; Sokka, Tuulikki Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 5(2013) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Good medium-term efficacy of tocilizumab in DMARD and anti-TNF-α therapy resistant reactive amyloidosis. Issue 3 (12th November 2012) Authors: Hakala, Markku; Immonen, Kai; Korpela, Markku; Vasala, Mikko; Kauppi, Markku J Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 3(2013) Page Start: 464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). Issue 6 (30th June 2012) Authors: Leirisalo-Repo, Marjatta; Kautiainen, Hannu; Laasonen, Leena; Korpela, Markku; Kauppi, Markku J; Kaipiainen-Seppänen, Oili; Luosujärvi, Riitta; Luukkainen, Reijo; Karjalainen, Anna; Blåfield, Harri; Uutela, Toini; Ilva, Kirsti; Julkunen, Heikki A; Paimela, Leena; Puolakka, Kari; Moilanen, Eeva; H... Other Names: Alasaarela Eeva author non-byline.; Eklund Kari K author non-byline.; Hakola Mikko author non-byline.; Kononoff Aulikki author non-byline.; Krogerus Maija-Liisa author non-byline.; Laiho Kari author non-byline.; Malmi Timo author non-byline.; Niinisalo Helena author non-byline.; Peltomaa Ritva au... Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 6(2013) Page Start: 851 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-Term Real-Life Experience With Rituximab in Adult Finnish Patients With Rheumatoid Arthritis Refractory or With Contraindication to Anti–Tumor Necrosis Factor Drugs. Issue 1 (January 2015) Authors: Valleala, Heikki; Korpela, Markku; Hienonen-Kempas, Tuija; Immonen, Kai; Lähteenmäki, Jukka; Uusitalo, Tea; Komulainen, Riitta; Möttönen, Timo; Hannonen, Pekka Journal: Journal of clinical rheumatology Issue: Volume 21:Issue 1(2015:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-Term Real-Life Experience With Rituximab in Adult Finnish Patients With Rheumatoid Arthritis Refractory or With Contraindication to Anti–Tumor Necrosis Factor Drugs. Issue 1 (January 2015) Authors: Valleala, Heikki; Korpela, Markku; Hienonen-Kempas, Tuija; Immonen, Kai; Lähteenmäki, Jukka; Uusitalo, Tea; Komulainen, Riitta; Möttönen, Timo; Hannonen, Pekka Journal: Journal of clinical rheumatology Issue: Volume 21:Issue 1(2015:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACo trial. Issue 4 (2nd December 2013) Authors: Rantalaiho, Vappu; Kautiainen, Hannu; Korpela, Markku; Puolakka, Kari; Blåfield, Harri; Ilva, Kirsti; Hannonen, Pekka; Leirisalo-Repo, Marjatta; Möttönen, Timo Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 4(2014) Page Start: 788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Serum β2 microglobulin correlates with the new ESSDAI in patients with Sjögren's syndrome. Issue 12 (30th May 2011) Authors: Pertovaara, Marja; Korpela, Markku Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 12(2011) Page Start: 2236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗